Berkshire Asset Management LLC Pfizer Inc Transaction History

Berkshire Asset Management LLC

$2.08 Billion
Q1 2025

A detailed history of Berkshire Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Berkshire Asset Management LLC holds 136,608 shares of PFE stock, worth $3.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

136,608

Previous 669,239 79.59%

Holding current value

$3.2 Million

Previous $17.8 Million 80.51%

% of portfolio

0.17%

Previous 0.89%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$25.01 - $27.13 $13.3 Million - $14.5 Million	-532,631 Reduced 79.59%	136,608 $3.46 Million
Q4 2024 Feb 06, 2025	SELL	$24.8 - $30.19 $851,235 - $1.04 Million	-34,324 Reduced 4.88%	669,239 $17.8 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $378,824 - $443,911	14,997 Added 2.18%	703,563 $19.7 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $82,226 - $94,422	3,176 Added 0.46%	688,566 $19.1 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $551,604 - $716,473	-21,110 Reduced 2.99%	685,390 $19.7 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $165,391 - $193,326	-5,154 Reduced 0.72%	706,500 $23.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $461,360 - $533,783	12,773 Added 1.83%	711,654 $26.1 Million
Q1 2023 Jun 06, 2023	SELL	$39.39 - $51.28 $265,488 - $345,627	-6,740 Reduced 0.96%	698,881 $28.5 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $258,015 - $336,810	6,180 Added 0.88%	705,621 $36.2 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $309,076 - $377,305	-7,063 Reduced 1.0%	699,441 $30.6 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $638,345 - $756,877	13,719 Added 1.98%	706,504 $37 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $326,746 - $404,879	7,142 Added 1.04%	692,785 $35.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $57,765 - $85,627	-1,398 Reduced 0.2%	685,643 $40.5 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $194,169 - $249,427	4,947 Added 0.73%	687,041 $29.6 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $1.46 Million - $1.65 Million	40,648 Added 6.34%	682,094 $26.7 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.03 Million - $1.16 Million	-30,659 Reduced 4.56%	641,446 $23.2 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.85 Million - $2.35 Million	55,182 Added 8.94%	672,105 $24.7 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $1.26 Million - $1.48 Million	-39,817 Reduced 6.06%	616,923 $22.6 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $182,768 - $221,724	-6,068 Reduced 0.92%	656,740 $21.5 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $658,018 - $940,165	24,344 Added 3.81%	662,808 $21.6 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $217,732 - $247,099	-6,614 Reduced 1.03%	638,464 $25 Million
Q3 2019 Oct 07, 2019	BUY	$32.49 - $42.13 $146,432 - $189,879	4,507 Added 0.7%	645,078 $23.2 Million
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $106,539 - $119,619	-2,881 Reduced 0.45%	640,571 $27.8 Million
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $128,662 - $141,357	-3,431 Reduced 0.53%	643,452 $27.3 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $204,583 - $233,247	-5,318 Reduced 0.82%	646,883 $28.2 Million
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $807,735 - $979,733	23,433 Added 3.73%	652,201 $28.7 Million
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $494,205 - $526,872	14,985 Added 2.44%	628,768 $22.8 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $649,432 - $753,431	20,352 Added 3.43%	613,783 $21.8 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $1.19 Million - $1.27 Million	35,905 Added 6.44%	593,431 $21.5 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $17.3 Million - $19 Million	557,526	557,526 $19.9 Million

Others Institutions Holding PFE

# of Institutions

3,368

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Asset Management LLC with notifications on news.

Account

Berkshire Asset Management LLC Pfizer Inc Transaction History